Objective: To demonstrate the benefits of a hyperimmune egg powder supplement for treating irritable bowel syndrome in 2 patients.
Clinical features: The first patient, not under chiropractic care, had been diagnosed with irritable bowel syndrome by her primary care physician. She sought care due to failure of several other alternative therapies. Her primary care physician ordered specific dietary modifications, yet this regimen did not appear to improve her symptoms. The second patient, also diagnosed with irritable bowel syndrome by her primary care physician, decided to seek care because the attending physician was concurrently treating her for idiopathic scoliosis, and both treatments could be administered at 1 office visit. Her primary reason for seeking this treatment was her longstanding episodic intestinal cramping and diarrhea. She overheard another patient in the same clinic discussing how the hyperimmune egg powder had alleviated her digestive complaints and decided to undergo a 2-week trial of the hyperimmune egg powder.
Intervention and outcome: The first subject was given a 31- day supply of the hyperimmune egg powder. She reported significant subjective improvement in frequency of defecation and stool consistency after 48 hours. She kept a daily journal to monitor her bowel habits during the trial period. The second subject was provided a 15-day supply of hyperimmune egg powder and instructed to keep the same daily journal to monitor her bowel habits. During the second week of the trial, she noticed less frequent bowel habits and a more solid stool consistency. However, shortly after she stopped taking the hyperimmune egg powder, the pre-trial symptoms returned. Because of this, she was put back on the hyperimmune egg powder, and the symptoms improved thereafter.
Conclusion: The addition of hyperimmune egg powder into an ordinary daily diet may have improved bowel function in 2 subjects, at least subjectively. However, it is unclear whether the subjective improvements are due to the hyperimmune egg powder or any psychosomatic effect created by physician contact, regardless of treatment type. This study should be repeated on a larger scale with a control group before any conclusions are made.
A diet low in FODMAPs reduces symptoms of irritable bowel syndrome.Gastroenterology. 2014 Jan;146(1):67-75.e5. doi: 10.1053/j.gastro.2013.09.046. Epub 2013 Sep 25. Gastroenterology. 2014. PMID: 24076059 Clinical Trial.
"Is It Her Hormones?": Psychiatric Diagnoses and Polycystic Ovarian Syndrome.J Dev Behav Pediatr. 2016 Jan;37(1):103-4. doi: 10.1097/DBP.0000000000000243. J Dev Behav Pediatr. 2016. PMID: 26703328
Eluxadoline benefits patients with irritable bowel syndrome with diarrhea in a phase 2 study.Gastroenterology. 2013 Aug;145(2):329-38.e1. doi: 10.1053/j.gastro.2013.04.006. Epub 2013 Apr 9. Gastroenterology. 2013. PMID: 23583433 Clinical Trial.
[Irritable bowel syndrome. Survey of definitions, differential diagnosis and pathogenesis].Lakartidningen. 2001 Feb 14;98(7):666-71. Lakartidningen. 2001. PMID: 11475255 Review. Swedish.
Update on the Management of Diarrhea-Predominant Irritable Bowel Syndrome: Focus on Rifaximin and Eluxadoline.Pharmacotherapy. 2016 Mar;36(3):300-16. doi: 10.1002/phar.1712. Epub 2016 Mar 11. Pharmacotherapy. 2016. PMID: 26971716 Review.